Comparative Effectiveness of Ivabradine Versus Digoxin in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort Study
In this large, real-world cohort of patients with HFrEF and CKD, ivabradine was associated with lower risks of MACE, HFE, and all-cause mortality compared with digoxin. Ivabradine may represent a safer and more effective heart-rate-lowering option for this high-risk population.
Authors
- Hsuan-Yuan Chang (ORCID: https://orcid.org/0009-0000-5014-5089)
- Keng-Wei Lee
- Sheng-Chi Huang
- Jheng-Yan Wu
- Yu-Min Lin
Publication Details
- Journal
- Cardiorenal Medicine
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1159/000551617
- Primary Topic
- Heart rate and cardiovascular health
- Type
- article
- Field-Weighted Citation Impact
- 0.00